We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+4.92%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$102B
AUM Growth
+$6.21B
Cap. Flow
-$328M
Cap. Flow %
-0.32%
Top 10 Hldgs %
16.35%
Holding
9,167
New
1,076
Increased
3,582
Reduced
3,580
Closed
702

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 8.48%
2 Financials 7.3%
3 Industrials 6.42%
4 Technology 5.35%
5 Energy 5.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SZYM
5601
PUT
DELISTED
SOLAZYME INC COM STK (DE)
SZYM
$245K ﹤0.01%
94,900
+56,200
+145% +$246K
RKUS
5602
PUT
DELISTED
RUCKUS WIRELESS INC COM STK (DE)
RKUS
$245K ﹤0.01%
20,400
-2,400
-11% -$29K
EFZ icon
5603
ProShares Trust Short MSCI EAFE
EFZ
$10.1M
$244K ﹤0.01%
+3,541
New +$241K
LGND icon
5604
Ligand Pharmaceuticals
LGND
$6.02B
$244K ﹤0.01%
7,355
+2,540
+53% +$82.6K
NGL icon
5605
CALL
NGL Energy Partners
NGL
$2.17B
$244K ﹤0.01%
8,700
+6,500
+295% +$213K
NVRO
5606
DELISTED
NEVRO CORP.
NVRO
$244K ﹤0.01%
+6,304
New +$199K
ECOM
5607
CALL
DELISTED
CHANNELADVISOR CORPORATION
ECOM
$244K ﹤0.01%
11,300
-10,200
-47% -$175K
MM
5608
DELISTED
MILLENNIAL MEDIA INC COM STK (DE)
MM
$244K ﹤0.01%
152,254
-4,197
-3% -$7.44K
BSET icon
5609
Bassett Furniture
BSET
$176M
$243K ﹤0.01%
12,456
-20,308
-62% -$364K
BBBY
5610
PUT
Bed Bath & Beyond
BBBY
$429M
$243K ﹤0.01%
13,310
-8,385
-39% -$142K
FSTR icon
5611
PUT
Foster
FSTR
$438M
$243K ﹤0.01%
+5,000
New +$244K
GIL icon
5612
CALL
Gildan
GIL
$10.8B
$243K ﹤0.01%
8,600
+1,000
+13% +$28.5K
KPTI icon
5613
CALL
Karyopharm Therapeutics
KPTI
$44.2M
$243K ﹤0.01%
433
+60
+16% +$34.1K
LBY
5614
DELISTED
Libbey, Inc.
LBY
$243K ﹤0.01%
+7,743
New +$222K
RPTP
5615
PUT
DELISTED
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
$243K ﹤0.01%
23,100
+13,400
+138% +$131K
HI
5616
PUT
DELISTED
Hillenbrand
HI
$242K ﹤0.01%
7,000
+2,800
+67% +$91.2K
STLA icon
5617
CALL
Stellantis
STLA
$20.9B
$242K ﹤0.01%
+32,055
New +$238K
UVV icon
5618
CALL
Universal Corp
UVV
$1.27B
$242K ﹤0.01%
5,500
-8,300
-60% -$350K
GARS
5619
DELISTED
Garrison Capital Inc.
GARS
$242K ﹤0.01%
+16,738
New +$246K
SHOR
5620
DELISTED
ShoreTel, Inc.
SHOR
$242K ﹤0.01%
32,990
-157,999
-83% -$1.17M
ANAC
5621
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
$242K ﹤0.01%
7,503
-321,474
-98% -$9.65M
MDXG icon
5622
CALL
MiMedx Group
MDXG
$609M
$241K ﹤0.01%
20,900
+17,900
+597% +$177K
WNC icon
5623
PUT
Wabash National
WNC
$512M
$241K ﹤0.01%
19,500
+15,200
+353% +$173K
NUVA
5624
PUT
DELISTED
NuVasive, Inc.
NUVA
$241K ﹤0.01%
5,100
-11,100
-69% -$463K
MTEM
5625
DELISTED
Molecular Templates, Inc.
MTEM
$241K ﹤0.01%
458
-254
-36% -$127K

Similar funds

Citadel Advisors's Q4 2014 Portfolio in Review

As of Q4 2014, Citadel Advisors held 9,167 positions worth $102B, up 6.5% from $95.5B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Citadel Advisors's Q4 2014 filing shows 1,076 new, 3,582 increased, 3,580 reduced and 702 closed positions. Its largest new stake was SIGMA - ALDRICH CORP: 1,469,606 shares worth $202M. The largest sale was COVIDIEN PLC COM SHS NEW (IRELAND), an estimated $288M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 8.5% of assets, up from 7.2% a quarter earlier, followed by Financials and Industrials.

  • Citadel Advisors's largest Q4 2014 buy was SIGMA - ALDRICH CORP: 1,469,606 shares worth $202M.
  • Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q4 2014, an estimated $1.04B increase.
  • Citadel Advisors's biggest Q4 2014 reduction was Union Pacific, cutting an estimated $283M.
  • Citadel Advisors fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q4 2014, selling an estimated $288M.
  • Citadel Advisors's ten largest holdings make up 16% of its $102B portfolio in Q4 2014.
  • Citadel Advisors opened 1,076 new positions and closed 702 in Q4 2014.
  • Citadel Advisors's portfolio value rose 6.5% quarter-over-quarter to $102B.

Based on Citadel Advisors's 13F filing for Q4 2014, filed 17 Feb 2015.